Comparing Immune Responses to Japanese Encephalitis Virus Vaccines
Author Information
Author(s): Ahsan Mohammad Feraz, Gore Milind M
Primary Institution: National Institute of Virology, Pune, India
Hypothesis
Does targeting antigen presenting cells with specific promoters enhance the immune response to Japanese encephalitis virus vaccines?
Conclusion
The study found that DNA vaccines targeting antigen presenting cells induce comparable immunity to those using ubiquitous promoters.
Supporting Evidence
- Immunization with plasmids led to the production of neutralizing antibodies against JEV.
- Protection rates were 87.5% for the CMV promoter and 75% for the macrophage promoter.
- Cytokine profiling showed a skewed Th1 response for the APC promoter.
Takeaway
Researchers tested different vaccines to see which one helps mice fight off a virus better, and found that both types worked well.
Methodology
Mice were immunized with plasmids expressing JEV E protein under different promoters, followed by evaluation of immune responses and protection against lethal virus challenge.
Limitations
The immune response was non-significantly lower for the APC dominant promoter compared to the CMV promoter.
Participant Demographics
Female BALB/c mice aged 4-5 weeks were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website